A Study of MEDI5395 in Combination With Durvalumab in Participants With Select Advanced Solid Tumors
Clinical trial NCT03889275 · COMPLETED
Trial details
- NCT number
- NCT03889275
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-24
- Primary completion
- 2021-11-19
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.